Astrazeneca (AZN) FCF Payout Ratio (2009 - 2026)
Astrazeneca (AZN) recorded quarterly FCF Payout Ratio of 6.01 in Q1 2026, down 177.15% quarter-over-quarter from 2.17 in Q4 2025, and up 22.98% on a YoY basis from 4.89 in Q1 2025.
Astrazeneca (AZN) FCF Payout Ratio (2009 - 2026) Analysis & Trends
Astrazeneca's FCF Payout Ratio history runs 17 years deep, the most recent figure standing at 6.01 for Q1 2026.
- In Q1 2026, FCF Payout Ratio rose 22.98% year-over-year to 6.01; the TTM figure through Mar 2026 stood at 1.87 (up 17.19% YoY), while the FY2025 annual figure was 0.31, down 5.6% from the prior year.
- FCF Payout Ratio was 6.01 for Q1 2026 at Astrazeneca, down from 2.17 in the prior quarter.
- In the past five years, FCF Payout Ratio ranged from a high of 0.02 in Q2 2025 to a low of 13.57 in Q1 2022.
- Historically, FCF Payout Ratio has averaged 4.86 across 5 years, with a median of 3.36 in 2024.
- The sharpest annual moves came in 2022 and 2025: FCF Payout Ratio decreased 20.88% in 2022, then soared 65.9% in 2025.
- A 5-year view of FCF Payout Ratio shows it stood at 13.57 in 2022, then surged by 99.4% to 0.08 in 2023, then slumped by 3517.33% to 2.95 in 2024, then rose by 26.44% to 2.17 in 2025, then sank by 177.15% to 6.01 in 2026.
- The last three FCF Payout Ratio figures came in at 6.01 (Q1 2026), 2.17 (Q4 2025), and 2.35 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn | -0.41 |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn | 0.51 |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn | 2.14 |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn | 0.87 |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn | 0.72 |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn | 0.92 |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn | 0.43 |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn | 1.12 |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn | 1.69 |
| 10 | Astrazeneca | 72.15 Bn | 64.21 Bn | 12.61 Bn | -6.01 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.01 |
| Dec 31, 2025 | -2.17 |
| Sep 30, 2025 | -2.35 |
| Jun 30, 2025 | -0.02 |
| Mar 31, 2025 | -7.80 |
| Dec 31, 2024 | -2.95 |
| Sep 30, 2024 | -3.78 |
| Jun 30, 2024 | -0.04 |
| Mar 31, 2024 | -7.27 |
| Jun 30, 2023 | -0.08 |
| Mar 31, 2023 | -12.34 |
| Mar 31, 2022 | -13.57 |
| Dec 31, 2021 | -8.10 |
| Sep 30, 2021 | -5.33 |
| Mar 31, 2021 | -11.22 |
| Mar 31, 2020 | -12.89 |
| Sep 30, 2019 | -5.49 |
| Mar 31, 2019 | 11.42 |
| Sep 30, 2018 | -4.82 |
| Mar 31, 2016 | -9.02 |